Protective Role of Genetic Variants in HSP90 Genes-Complex in COPD Secondary to Biomass-Burning Smoke Exposure and Non-Severe COPD Forms in Tobacco Smoking Subjects
- PMID: 34449539
- PMCID: PMC8928934
- DOI: 10.3390/cimb43020063
Protective Role of Genetic Variants in HSP90 Genes-Complex in COPD Secondary to Biomass-Burning Smoke Exposure and Non-Severe COPD Forms in Tobacco Smoking Subjects
Abstract
Background: Chronic Obstructive Pulmonary Disease (COPD) is an inflammatory disease characterized by airflow obstruction, commonly present in smokers and subjects exposed to noxious particles product of biomass-burning smoke (BBS). Several association studies have identified single-nucleotide polymorphisms (SNP) in coding genes related to the heat shock proteins family-genes that codify the heat shock proteins (Hsp). Hsp accomplishes critical roles in regulating immune response, antigen-processing, eliminating protein aggregates and co-activating receptors. The presence of SNPs in these genes can lead to alterations in immune responses. We aimed to evaluate the association of SNPs in the HSP90 gene complex and COPD.
Methods: We enrolled 1549 participants, divided into two comparison groups; 919 tobacco-smoking subjects (cases COPD-TS n = 294 and, controls SWOC n = 625) and 630 chronic exposed to BBS (cases COPD-BBS n = 186 and controls BBES n = 444). We genotyped 2 SNPs: the rs13296 in HSP90AB1 and rs2070908 in HSP90B1.
Results: Through the dominant model (GC + CC), the rs2070908 is associated with decreased risk (p < 0.01, OR = 0.6) to suffer COPD among chronic exposed BBS subjects. We found an association between rs13296 GG genotype and lower risk (p = 0.01, OR = 0.22) to suffer severe COPD-TS forms in the severity analysis.
Conclusions: single-nucleotide variants in the HSP90AB1 and HSP90B1 genes are associated with decreased COPD risk in subjects exposed to BBS and the most severe forms of COPD in tobacco-smoking subjects.
Keywords: COPD; HSP90; SNPs; biomass-burning; smoking.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
References
-
- GOLD Global Initiative for Chronic Obstructive Lung Disease: Pocket Guide to COPD Diagnosis, Management, and Prevention, a Guide for Health Care Professionals. Gold. 2021. [(accessed on 20 April 2021)]. pp. 1–33. Available online: www.goldcopd.org.
-
- Hogg J.C. Pathophysiology of airflow limitation in chronic obstructive pulmonary disease. [(accessed on 29 August 2020)];Lancet. 2004 364:709–721. doi: 10.1016/S0140-6736(04)16900-6. Available online: http://www.ncbi.nlm.nih.gov/pubmed/15325838. - DOI - PubMed
-
- Raskin J., Marks T., Miller A. Phenotypes and Characterization of COPD. [(accessed on 15 July 2019)];J. Cardiopulm. Rehabil. Prev. 2017 Available online: http://insights.ovid.com/crossref?an=01273116-900000000-99625. - PubMed
-
- Solus J.F., Chung C.P., Oeser A., Li C., Rho Y.H., Bradley K.M., Kawai V.K., Smith J.R., Stein C.M. Genetics of serum concentration of IL-6 and TNFalpha in systemic lupus erythematosus and rheumatoid arthritis: A candidate gene analysis. Clin. Rheumatol. 2015;34:1375–1382. doi: 10.1007/s10067-015-2881-6. - DOI - PMC - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
